Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Biosimilars [Design Issues]

posted by M.Vasu – India, 2011-11-24 15:01 (5317 d 03:25 ago) – Posting: # 7712
Views: 10,672

Hi,

Can any one explain regarding BE study procedure for Biosimilars (Injection) in healthy subjets?

Thanks,

VM..........

Edit: Category changed. [Helmut]

Complete thread:

BiosimilarsM.Vasu 2011-11-24 14:01 [Design Issues]
- Biosimilars Helmut 2011-11-24 14:44
  - Biosimilars M.Vasu 2011-11-28 12:33
    - Healthy subjects vs. patients Helmut 2011-11-28 12:56
    - Biosimilars drgunasakaran1 2012-02-06 13:57
  - Biosimilars Ben 2011-12-16 19:04
- Biosimilars Chiku 2012-02-03 06:43
  - Biosimilars drgunasakaran1 2012-02-10 11:33
    - Biosimilars Chiku 2012-02-10 12:03
      - Biosimilars Kumarnaidu2 2021-10-22 07:53

Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
134 visitors (0 registered, 134 guests [including 14 identified bots]).
Forum time: 19:26 CEST (Europe/Vienna)

The idea is to try and give all the information to help others
to judge the value of your contribution;
not just the information that leads to judgment
in one particular direction or another. Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz